FDA Inspection 1036804 — Aeterna Zentaris Gmbh
The FDA completed an inspection of Aeterna Zentaris Gmbh on Nov 16, 2017 in Frankfurt am Main. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Frankfurt am Main (Germany)
Additional Details
Sponsor, Contract Research Organization